Screener
Kestra Medical Technologies KMTS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Kestra Medical Technologies’s reported figures.
The source filing: Kestra Medical Technologies’s 10-Q, filed September 14, 2026. Open the filing →
- Filed
- Sep 14, 2026, 5:15 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001193125-26-390766
FAQ
- What is Kestra Medical Technologies's free cash flow?
- Kestra Medical Technologies (KMTS) reported free cash flow of -$40.63M in Q2 2026.
- How has Kestra Medical Technologies's free cash flow changed year-over-year?
- Kestra Medical Technologies's free cash flow decreased by 18.0% year-over-year, from -$34.44M to -$40.63M.
- What is the long-term trend for Kestra Medical Technologies's free cash flow?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's free cash flow has grown at a 17.5% compound annual growth rate (CAGR), from -$84.46M to -$116.6M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Kestra Medical Technologies's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude